Public Companies

Apr. 19, 2026

Pegasystems Earnings Expected on Tuesday

Analysts project Q1 2026 results for the software company.

Apr. 17, 2026

Zenas BioPharma Announces Inducement Grants

Biotech firm grants restricted stock units to new hires under Nasdaq listing rule

Apr. 17, 2026

Boston Scientific Faces Cardiovascular Test in Q1 Earnings

Robust performance in Cardiovascular and steady MedSurg growth expected to drive solid revenue and earnings gains.

Apr. 17, 2026

Boston Beer's Q1 Earnings on Horizon: What Surprise Awaits Investors?

SAM faces Q1 pressure as weak demand, seltzer struggles and rising costs weigh on sales and earnings outlook.

Apr. 16, 2026

Kailera Therapeutics Prices $625M IPO

Biotech firm focused on obesity treatments goes public on Nasdaq

Apr. 16, 2026

Netcapital Appoints Todd Violette as Chief Executive Officer

Veteran fintech executive to lead capital formation and platform expansion

Apr. 16, 2026

DraftKings to Launch Online Sportsbook and Casino in Alberta

Pending regulatory approval, the company plans to expand its digital gaming offerings to the Canadian province.

Apr. 16, 2026

Ardelyx to Report Q1 2026 Earnings on April 30

Biopharmaceutical company to host webcast and conference call to discuss financial results and business update.

Apr. 15, 2026

Pegasystems Stock Receives $67.60 Consensus Price Target

Wall Street analysts see upside potential in the enterprise software company's shares.

Apr. 14, 2026

ImmunityBio Founder Disputes FDA Warning Over Anktiva Claims

Patrick Soon-Shiong says TV ad referenced in letter 'never aired at all'

Apr. 14, 2026

IMPLANET Reports Q1 2026 Revenue of €3.03 Million, up 18%

Strong momentum in the United States, +167% in Q1 2026

Apr. 14, 2026

Chelsea Made More Player Sale Profit Under Abramovich Than New Owners

Shocking figures show Chelsea's player trading struggles under new ownership.